Overview

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets

Status:
Recruiting
Trial end date:
2021-08-15
Target enrollment:
Participant gender:
Summary
This study is a single-center, open, single-arm study, conducted in healthy Chinese populations, and plans to enroll 22 healthy adult subjects (the ratio of either sex is not less than 1/3).
Phase:
Phase 1
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.
Collaborator:
The Fourth Hospital of Hebei Medical University
Treatments:
Metformin